KA
DXCM icon

Kovack Advisors’s DexCom DXCM Stock Holding History

Kovack Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,992
Closed -$269K – 707
2021
Q1 		$269K Sell
2,992
-800
-21% -$75.1K 0.04% 504
2020
Q4 		$350K Sell
3,792
-4,592
-55% -$410K 0.05% 357
2020
Q3 		$864K Buy
8,384
+6,248
+293% +$653K 0.15% 155
2020
Q2 		$216K Buy
+2,136
New +$191K 0.04% 393

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Kovack Advisors's DXCM Position: Q2 2021 in Review

Kovack Advisors sold out of DexCom (DXCM) in Q2 2021, closing a stake of 2,992 shares — an estimated $269K sold.

Kovack Advisors first reported a position in DXCM in Q2 2020 and held it in 4 quarters. The position peaked at $864K in Q3 2020. 726 funds tracked by Wall St. Rank hold DXCM as of Q2 2021.

  • Kovack Advisors reported no remaining DexCom position as of Q2 2021 after selling out during the quarter.
  • Kovack Advisors sold 2,992 DexCom shares in Q2 2021, an estimated $269K.
  • Kovack Advisors first reported a position in DexCom in Q2 2020 and held it in 4 quarters.
  • Kovack Advisors's DexCom position peaked at $864K in Q3 2020.
  • 726 funds tracked by Wall St. Rank held DexCom as of Q2 2021.

Based on Kovack Advisors's 13F filing for Q2 2021, filed 29 Jul 2021.